Compounds > cytarabine

cytarabine and Harringtonine

cytarabine has been researched along with Harringtonine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ren, L; Yang, J; Zhang, H; Zhang, Z1
Chen, Q; Du, QF; Li, R; Liu, QF; Liu, XL; Zhou, SY1
Chen, Y; He, M; Li, H; Wu, Y; Xiang, Z; Yu, D; Yue, B1
Bai, J; Cao, YR; Cui, ZZ; Fu, R; He, GS; Jia, HR; Liu, H; Qin, TJ; Shao, ZH; Shi, J; Sun, J; Tu, HF; Wu, YH; Yang, TY; Zhao, MF1
Cheng, YQ; DU, LJ; Fu, R; Gao, S; Guan, J; Jiang, HJ; Li, LJ; Liang, Y; Liu, CY; Liu, H; Liu, WH; Qu, W; Ruan, EB; Shao, ZH; Song, J; Song, WX; Song, Y; Wang, GJ; Wang, J; Wang, XM; Zhang, LT; Zhang, RL; Zou, P1
Carter, BZ; Dai, M; Ding, B; Jiang, L; Jiang, X; Liang, S; Liu, Q; Meng, F; Wang, Z; Ye, J; Yin, C; Yu, G; Zhang, Y; Zhao, Q; Zhong, Q1

Other Studies

6 other study(ies) available for cytarabine and Harringtonine

ArticleYear
A sequential study on the use of the cytokinesis-block micronucleus method in mouse splenocytes.
    Mutation research, 1993, Volume: 301, Issue:4

    Topics: 2-Acetylaminofluorene; Animals; Cell Cycle; Cell Division; Chromates; Cisplatin; Colchicine; Cytarabine; Harringtonines; Male; Methyl Methanesulfonate; Mice; Mice, Inbred C57BL; Micronucleus Tests; Mutagens; Potassium Compounds; Spleen; Vincristine

1993
[Quantitative analysis of Sokal's risk index in relation to 2 therapy protocols: their respective impact on clinical remission of chronic myeloid leukemia].
    Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2002, Volume: 22, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cytarabine; Female; Harringtonines; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Outcome Assessment, Health Care; Treatment Outcome

2002
The comprehensive evaluation on four indices of drug resistance in acute myeloid leukemia.
    Journal of Tongji Medical University = Tong ji yi ke da xue xue bao, 1999, Volume: 19, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; bcl-2-Associated X Protein; Cell Division; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Harringtonines; Humans; Leukemia, Myeloid, Acute; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Stem Cell Assay

1999
[Preliminary study of DA or HA regimen chemotherapy for the treatment of refractory and relapsed paroxysmal nocturnal hemoglobinuria].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2004, Volume: 25, Issue:4

    Topics: Adolescent; Adult; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Glycosylphosphatidylinositols; Harringtonines; Hemoglobinuria, Paroxysmal; Humans; Male

2004
[Analysis on prognosis and correlative factors of acute nonlymphocytic leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2007, Volume: 15, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Harringtonines; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Tretinoin; Young Adult

2007
The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients.
    Oncotarget, 2015, Oct-20, Volume: 6, Issue:32

    Topics: Aclarubicin; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Line, Tumor; Cytarabine; Decitabine; Disease-Free Survival; Female; Harringtonines; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Young Adult

2015